Question 1

What is Aurinia Pharmaceuticals?

Accepted Answer

Aurinia Pharmaceuticals is a Company.

Question 2

How often does Aurinia Pharmaceuticals appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 6 articles.

Question 3

When was Aurinia Pharmaceuticals first tracked by Ergen?

Accepted Answer

First tracked on Jul 06, 2026.

Question 4

When was Aurinia Pharmaceuticals last mentioned in news?

Accepted Answer

Last active on Jul 06, 2026.

Question 5

What is Aurinia Pharmaceuticals's current news sentiment?

Accepted Answer

Aggregate sentiment score: 70 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Aurinia Pharmaceuticals in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Aurinia Pharmaceuticals?

Accepted Answer

Aurinia Initiates PRESERVE Lupus Nephritis Study (Jul 06, 2026, 6 articles).

Question 8

How did the "Aurinia Initiates PRESERVE Lupus Nephritis Study" event impact Aurinia Pharmaceuticals?

Accepted Answer

Aurinia Pharmaceuticals initiated the PRESERVE study, which could lead to improved treatments for lupus nephritis and potentially increase the market for its drug LUPKYNIS.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.